TMPRSS2 and prostate cancer: Fine et al. conducted FISH analysis in a cohort of prostate cancer patients who underwent radical prostatectomy without neoadjuvant therapy study to investigate the correlation between TMPRSS2:ERG fusion and the Gleason score.